http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014155678-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5679b0dbe4c28b66dc9eae65408a8d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb975053e4d4c4872e25807f6154d786
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_836773f95317e59b102556bf5858f18c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c6f2399006d8f7b556f80b2ce963301
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 2012-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e726a80d1d07f722532354f99b2ed241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca23890a623ef73420e22450f8f0f631
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af2c0cbf0a1ce39d4656618404edcf9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_915146f15356bbfdb6cf251712f75edc
publicationDate 2014-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2014155678-A1
titleOfInvention Focused radiation for augmenting immune-based therapies against neoplasms
abstract An approach combining immune-based therapies with focused radiation, including stereotactic radiation, to treat cancers is disclosed. The use of focused radiation primes the immune system in a similar manner to vaccines to augment immune-based therapies and can counteract the suppressive effects of a tumor. The combination of focused radiation and immune-based therapies, including administration of at least one immunotherapeutic agent, improves survival compared to each therapy alone and can, in some cases, lead to a durable cure. Accordingly, focused radiation can be an adjuvant for immune-based therapies for treating cancers.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10570204-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020132672-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884913-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9815898-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11344620-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10752687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10981990-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11155620-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9683048-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11365255-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9605070-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11382953-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11708412-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10344090-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022062655-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10472419-B2
priorityDate 2011-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011224141-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57469

Total number of triples: 49.